Code intelligence

C79.31 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code C79.31.

Normal code riskView ICD-10 detail

Signal breakdown

3 shown · 3 total in platform

Risk: Normal
0

Critical

0%

0

High

0%

3

Routine

100%

0

Low

0%

New this month

alerts added in last 30 days

Effective soon

no upcoming deadlines

LCD L37070: MolDX: DecisionDx-UM (Uveal Melanoma) — Noridian

Policy LCD-L37070 · Oncology

Routine

New LCD affects uveal melanoma billing effective 01/22/2026.

LCD L38566: MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells — Palmetto GBA

Policy LCD-L38566 · Oncology

Routine

New LCD requires billing team review.

LCD L38643: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells — Noridian

Policy LCD-L38643 · Oncology

Routine

New billing guidelines for circulating tumor cells from 2026.

Audit documentation

Building an audit file that includes C79.31?

The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Oncology audit pack — $349One-time purchase · not a subscription